In another study on breast tumors, an increase in the expression of phosphorylated p90RSK showed a proportional tumor size reduction by 12% during neoadjuvant chemotherapy, as measured by magnetic resonance imaging [68]. This evidence concerns the gene RPS6KA1 and neoplasm.